Not applicableStudy completedNCT04956198What this trial is testingDrug Sensitivity and Mutation ProfilingWho this might be right forEwing SarcomaOsteosarcomaRhabdomyosarcoma+4 more Florida International University 14
Large-scale testing (Phase 3)Study completedNCT00075582What this trial is testingVincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk RhabdomyosarcomaWho this might be right forAdult RhabdomyosarcomaEmbryonal Childhood RhabdomyosarcomaEmbryonal-botryoid Childhood Rhabdomyosarcoma+1 more Children's Oncology Group 390
Large-scale testing (Phase 3)Active Not RecruitingNCT04994132What this trial is testingCompare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk RhabdomyosarcomaWho this might be right forAlveolar RhabdomyosarcomaBotryoid-Type Embryonal RhabdomyosarcomaEmbryonal Rhabdomyosarcoma+5 more Children's Oncology Group 118
Testing effectiveness (Phase 2)Looking for participantsNCT06239272What this trial is testingNRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)Who this might be right forAdipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+6 more St. Jude Children's Research Hospital 139
Large-scale testing (Phase 3)Active Not RecruitingNCT02567435What this trial is testingCombination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaWho this might be right forAlveolar RhabdomyosarcomaBotryoid-Type Embryonal RhabdomyosarcomaEmbryonal Rhabdomyosarcoma+3 more National Cancer Institute (NCI) 325
Testing effectiveness (Phase 2)WithdrawnNCT04906876What this trial is testing9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced SarcomasWho this might be right forSarcomaSoft Tissue SarcomaMetastatic Sarcoma+10 more Brown University
Testing effectiveness (Phase 2)Study completedNCT00949325What this trial is testingSafety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent SarcomaWho this might be right forSarcoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Testing effectiveness (Phase 2)WithdrawnNCT05116800What this trial is testingPhase 2 Study of 9-ING-41 With Chemotherapy in SarcomaWho this might be right forSoft Tissue SarcomaUndifferentiated Pleomorphic SarcomaMyxofibrosarcoma+10 more Brown University
Testing effectiveness (Phase 2)Study completedNCT01962103What this trial is testingStudy to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsWho this might be right forNeuroblastomaRhabdomyosarcomaEwing's Sarcoma+20 more Celgene 107
Large-scale testing (Phase 3)Looking for participantsNCT05304585What this trial is testingChemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative RhabdomyosarcomaWho this might be right forEmbryonal RhabdomyosarcomaFusion-Negative Alveolar RhabdomyosarcomaSpindle Cell/Sclerosing Rhabdomyosarcoma Children's Oncology Group 205
Early research (Phase 1)Active Not RecruitingNCT04420975What this trial is testingNivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue SarcomaWho this might be right forLeiomyosarcomaMalignant Peripheral Nerve Sheath TumorMyxofibrosarcoma+27 more Jonsson Comprehensive Cancer Center 14
Not applicableNot Yet RecruitingNCT06526897What this trial is testingEvaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue SarcomaWho this might be right forAdult Pleomorphic RhabdomyosarcomaAJCC Grade 2 SarcomaAJCC Grade 3 Sarcoma+20 more ECOG-ACRIN Cancer Research Group 1,582